Last update: July 16, 2017

Eslicarbazepine

Low Risk for breastfeeding


Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.

Eslicarbazepine or S-licarbazepine is the S-enantiomer of licarbazepine (MHD), the active metabolite of oxcarbazepine (see specific information), an anti-epileptic drug considered to be of low risk during breastfeeding.

Since the last update we have not found any published data on its excretion in breast milk.

Given the structural equivalence and similar actions to oxcarbazepine, different effects are not likely in infants who are breastfed by mothers undergoing treatment with eslicarbazepine or oxcarbazepine, but until there is more data on this drug in relation to breastfeeding, safer known alternatives are preferred, especially in the neonatal period and in case of prematurity.


See below the information of this related product:

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Eslicarbazepine is also known as


Eslicarbazepine in other languages or writings:

Group

Eslicarbazepine belongs to this group or family:

Tradenames

Main tradenames from several countries containing Eslicarbazepine in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 90 %
Molecular weight 254 daltons
Protein Binding 40 %
VD 0,9 l/Kg
Tmax 2 - 3 hours
T1/2 20 - 24 hours

References

  1. Jacob S, Nair AB. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs R D. 2016 Abstract Full text (link to original source) Full text (in our servers)
  2. EMA. Eslicarbazepina. Ficha técnica. 2016 Full text (in our servers)
  3. EMA. Eslicarbazepine. Drug Summary. 2016 Full text (in our servers)
  4. Sunovion. Eslicarbazepine (Aptiom). Prescribing Information. 2015 Full text (in our servers)

Total visits

1,468

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM